DJIA 17,279.19 -137.66 -0.79%
NASDAQ 4,655.93 -27.48 -0.59%
S&P 500 2,001.47 -19.78 -0.98%
market minute promo

Ophthotec (NASDAQ: OPHT)

56.51 0.68 (1.22%)

Quote as of

company name or ticker

Recent Quotes

OPHT $56.51 1.22%
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $55.52
Previous Close $55.83
Daily Range $55.01 - $57.01
52-Week Range $29.01 - $57.97
Market Cap $1.9B
P/E Ratio 3.72
Dividend (Yield) $0.00 (0.0%)
Volume 53,059
Average Daily Volume 285,210
Current FY EPS -$2.39



Ophthotec (OPHT) Description

Ophthotech Corp is a biopharmaceutical company specializing in the development of novel therapeutics to treat diseases of the back of the eye with a focus on developing therapeutics for age-related macular degeneration. Website:

News & Commentary

5 Tiny Biotech Stocks to Own in 2015

Insys Therapeutics, Achillion Pharmaceuticals, Portola Pharmaceuticals, Ophthotech, and Acceleron Pharma have intriguing pipelines that may make them stocks to own this year.

Vertex Pharmaceuticals Slumps: VRTX Falls 5.9% in Session - Tale of the Tape

BioDelivery Signs Agreement with Meda for Onsolis - Analyst Blog

BioDelivery Signs Agreement with Meda for Onsolis - Analyst Blog

Illumina Tops Q4 Earnings on Solid Revenues, Margin Growth - Analyst Blog

Commit To Purchase Ophthotech Corp At $45, Earn 12.1% Annualized Using Options

A Company's First Profit Can Mean Big Profits to Investors - Screen of the Week

Will Ophthotech (OPHT) Continue to Surge Higher? - Tale of the Tape

The Small-Cap Stock I'm Watching in 2015

Three Motley Fools tell investors which small-cap stocks they'll be watching in 2015.

Could These Tiny Biotech Stocks Double in 2015?

Ophthotech Corporation, Achillion Pharmaceuticals, and Portola Pharmaceuticals all have catalysts that could lift shares in 2015.

Why Novartis and Regeneron Care About This Tiny Biotech Stock

Ophthotech's Fovista may tip the scale in favor of either Novartis' Lucentis or Regeneron's Eylea.

See More OPHT News...